What is Protrials?
ProTrials Research, Inc. operates as a premier, woman-owned full-service clinical research organization (CRO) headquartered in the United States. The company provides a comprehensive suite of services, including project management, clinical operations, quality assurance, and clinical data management. With deep therapeutic expertise spanning oncology, ophthalmology, central nervous system disorders, infectious diseases, and women's health, ProTrials serves as a critical partner for pharmaceutical, biotechnology, and medical device companies. Their market position is defined by a commitment to high-quality site management and collaborative clinical development, ensuring that complex research programs are executed with precision and regulatory compliance.
How much funding has Protrials raised?
Protrials has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Protrials
PPP
Public-Private Partnership
What's next for Protrials?
With the recent infusion of capital, ProTrials is poised to scale its service offerings and enhance its technological infrastructure to meet the evolving demands of global clinical trials. The strategic allocation of these funds will likely focus on deepening therapeutic specialization and expanding the firm's reach into emerging medical markets. As the CRO industry continues to consolidate, ProTrials' ability to maintain high-touch, professional service standards while scaling operations will be a key determinant of its long-term growth. The company is expected to leverage this financial backing to strengthen its competitive advantage in clinical data management and site oversight, further solidifying its reputation as a trusted partner in the life sciences ecosystem.
See full Protrials company page
